Trade Summary

2 weeks ago, GC Corp., serving as 10% owner Owner at Artiva Biotherapeutics, Inc. (ARTV), purchased 1,432,291 shares at $11.52 per share, for a total transaction value of $16,499,992.32. Following this transaction, GC Corp. now holds 1,607,734 shares of ARTV.

This purchase represents a 816.39% increase in GC Corp.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 11, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 28, 2026 at 4:34 PM ET, 17 days after the trade was made.

Artiva Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.